Health Care · Health Care Services · US stock · price as of 16 Oct 2026
Key indicators
Price
$302.30
52-week range
$234.20 – $304.44
Market cap
$79.8B
P/E (trailing)
12.9×
EV / EBITDA
8.3×
Free-cash-flow yield
12.9%
Dividend yield
2.0%
Revenue (last 12 months)
$282.4B
Revenue growth (3y a year)
15.0%
Operating margin
3.5%
Return on invested capital
11.8%
Net debt / EBITDA
2.0×
Fair value
Blended fair value$822.54 range $773 – $880
Versus priceData under review+0% to fair value
Peer multiples
$730.30
Fundamentals-adjusted multiple
$925.79
10-year DCF (market-scaled)
$811.54
Earnings power value (floor, not blended)
$353.99
Model uncertainty
Medium
X-Ray Score
66/ 100 · Medium confidence · ahead of 87% of sector peers
Valuation96
Growth68
Profitability51
Financial health48
Dividends63
Five-year price chart navy: price · brown: 200-day average · blue band: fair value range
Executive summary
Cigna Group is a health services company with two main parts: Evernorth, which includes pharmacy benefit management through Express Scripts and specialty care services, and Cigna Healthcare, which sells medical, dental and other insurance plans. Revenue comes from insurance premiums, fees for managing prescription drug benefits and the dispensing of medicines, and it depends on medical costs and regulation.
Over the last twelve months Cigna Group reported revenue of $282.4 billion. Over three years revenue has grown by 15.0% a year. The operating margin is 3.5%. Return on invested capital is 12%. Net debt to EBITDA is 2.0 times. It pays a dividend with a yield of 2.0%. Return on invested capital describes how much profit the business earns relative to the money put into it.
StocksXray gives Cigna Group an X-Ray Score of 66 out of 100 (medium confidence), ahead of 87% of the S&P 500 stocks in its sector. Its strongest lens is valuation (96) and its weakest is financial health (48).
Our fair value blend is $822.54 (range $772.73 to $879.81). At $302.30 the stock trades 63% below that blend, so the label is "Data under review" with medium model uncertainty. Fair value is a range, not a price target.
XStocksXray
Cigna Group (CI)
Valuation history multiples at each fiscal year-end price; the last column uses today's price and the last twelve months
FY2021
FY2022
FY2023
FY2024
FY2025
Now
Price
$210.29
$308.46
$283.86
$266.07
$270.64
$302.30
Market cap
$71.7B
$96.6B
$84.3B
$75.4B
$72.7B
$79.8B
P/E
13.4×
14.4×
16.3×
22.0×
12.2×
12.9×
EV / revenue
0.6×
0.7×
0.6×
0.4×
0.3×
0.4×
EV / EBITDA
9.3×
10.6×
9.3×
8.2×
8.0×
8.3×
Price / free cash flow
10.0×
11.2×
7.1×
7.3×
7.6×
7.8×
Free-cash-flow yield
10.0%
9.0%
14.0%
13.8%
13.2%
12.9%
Price / book
1.5×
2.2×
1.8×
1.8×
1.7×
1.9×
Dividend yield
1.90%
1.45%
1.73%
2.10%
2.23%
2.05%
Fundamentals checklist ● 5 Good · ● 5 Average · ● 4 Bad · each check graded against the sector
Cash quality
Earnings backed by cash−2.6%Bad
Risk models
Altman Z score1.5×Bad
Piotroski F-Score8 of 9Good
Growth
EPS growth (3y)1.2%Average
Revenue growth (3y)15.0%Good
Growth consistency100%Good
Balance sheet
Current ratio0.8×Bad
Net debt / EBITDA2.0×Average
Interest cover7.2×Average
Valuation
Fair value vs price2.7×Good
EBIT / EV yield9.4%Good
Profitability
Return on invested capital11.8%Average
Operating margin3.5%Bad
Gross profitability37.1%Average
XStocksXray
Cigna Group (CI)
Financials US$ millions, from SEC filings; last column is the last twelve months
Income statement
FY21
FY22
FY23
FY24
FY25
LTM
Revenue
174,069
180,518
195,265
247,121
274,900
282,382
Gross profit
56,516
55,684
61,464
64,612
59,909
58,254
Operating income
7,941
8,450
8,536
9,417
9,200
9,957
Net income
5,420
6,782
5,164
3,434
5,957
6,230
Diluted EPS ($)
15.75
21.41
17.39
12.12
22.18
23.42
Free cash flow
7,191
8,656
11,813
10,363
9,601
10,277
Gross margin
32.5%
30.8%
31.5%
26.1%
21.8%
20.6%
Operating margin
4.6%
4.7%
4.4%
3.8%
3.3%
3.5%
Net margin
3.1%
3.8%
2.6%
1.4%
2.2%
2.2%
Balance sheet
FY21
FY22
FY23
FY24
FY25
LTM
Total assets
154,889
143,885
152,761
155,881
157,919
157,082
Cash
5,081
5,924
7,822
7,550
7,676
6,298
Total debt
35,697
31,093
32,167
32,852
31,463
32,878
Equity
47,112
44,675
46,223
41,033
41,713
42,620
Dividend per share ($)
4.00
4.48
4.92
5.60
6.04
6.14
Revenue and net income US$ billions: navy revenue, teal net income
Every number comes from SEC filings, end-of-day prices and the StocksXray models described on the methodology page. The X-Ray Score ranks each metric against the company's own sector. Fair value blends three models and carries a typical error of about 40%, so treat it as a range. Analyst ratings, price targets and earnings-call summaries are not part of this report. Educational research, not financial advice; read the disclaimer.